学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
EFFECT OF VERAPAMIL ON DAUNORUBICIN ACCUMULATION IN EHRLICH ASCITES TUMOR-CELLS
被引:36
作者
:
FRICHE, E
论文数:
0
引用数:
0
h-index:
0
FRICHE, E
SKOVSGAARD, T
论文数:
0
引用数:
0
h-index:
0
SKOVSGAARD, T
NISSEN, NI
论文数:
0
引用数:
0
h-index:
0
NISSEN, NI
机构
:
来源
:
CANCER CHEMOTHERAPY AND PHARMACOLOGY
|
1987年
/ 19卷
/ 01期
关键词
:
D O I
:
10.1007/BF00296252
中图分类号
:
R73 [肿瘤学];
学科分类号
:
100214 ;
摘要
:
引用
收藏
页码:35 / 39
页数:5
相关论文
共 17 条
[1]
BACHUR NR, 1970, CANCER CHEMOTH REP 1, V54, P89
[2]
DANO K, 1972, CANCER RES, V32, P1307
[3]
DANO K, 1971, CANCER CHEMOTH REP 1, V55, P133
[4]
DANO K, 1983, 13TH P INT CANC C C, V2, P231
[5]
TUMOR-CELL RESISTANCE TO ANTHRACYCLINES - A REVIEW
KAYE, S
论文数:
0
引用数:
0
h-index:
0
KAYE, S
MERRY, S
论文数:
0
引用数:
0
h-index:
0
MERRY, S
[J].
CANCER CHEMOTHERAPY AND PHARMACOLOGY,
1985,
14
(02)
: 96
-
103
[6]
INTERACTIONS BETWEEN CALCIUM-ANTAGONISTS, CALCIUM FLUXES AND ANTHRACYCLINE TRANSPORT
KESSEL, D
论文数:
0
引用数:
0
h-index:
0
机构:
WAYNE STATE UNIV,SCH MED,DEPT PHARMACOL,DETROIT,MI 48201
KESSEL, D
WILBERDING, C
论文数:
0
引用数:
0
h-index:
0
机构:
WAYNE STATE UNIV,SCH MED,DEPT PHARMACOL,DETROIT,MI 48201
WILBERDING, C
[J].
CANCER LETTERS,
1984,
25
(01)
: 97
-
101
[7]
KESSEL D, 1985, CANCER RES, V45, P1687
[8]
CALCIUM MODIFIES THE ACCUMULATION AND RETENTION OF DAUNORUBICIN BY EHRLICH ASCITES-CARCINOMA
MURRAY, SL
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CALIF IRVINE,COLL MED,DEPT MED,IRVINE,CA 92717
UNIV CALIF IRVINE,COLL MED,DEPT MED,IRVINE,CA 92717
MURRAY, SL
DUVALL, EM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CALIF IRVINE,COLL MED,DEPT MED,IRVINE,CA 92717
UNIV CALIF IRVINE,COLL MED,DEPT MED,IRVINE,CA 92717
DUVALL, EM
SLATER, LM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CALIF IRVINE,COLL MED,DEPT MED,IRVINE,CA 92717
UNIV CALIF IRVINE,COLL MED,DEPT MED,IRVINE,CA 92717
SLATER, LM
[J].
CANCER CHEMOTHERAPY AND PHARMACOLOGY,
1984,
13
(01)
: 69
-
70
[9]
REVERSAL OF ADRIAMYCIN RESISTANCE BY VERAPAMIL IN HUMAN OVARIAN-CANCER
ROGAN, AM
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,MED BRANCH,BLDG 10,ROOM 12N226,BETHESDA,MD 20205
ROGAN, AM
HAMILTON, TC
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,MED BRANCH,BLDG 10,ROOM 12N226,BETHESDA,MD 20205
HAMILTON, TC
YOUNG, RC
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,MED BRANCH,BLDG 10,ROOM 12N226,BETHESDA,MD 20205
YOUNG, RC
KLECKER, RW
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,MED BRANCH,BLDG 10,ROOM 12N226,BETHESDA,MD 20205
KLECKER, RW
OZOLS, RF
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,MED BRANCH,BLDG 10,ROOM 12N226,BETHESDA,MD 20205
OZOLS, RF
[J].
SCIENCE,
1984,
224
(4652)
: 994
-
996
[10]
CHEMOSENSITIZERS COUNTERACTING ACQUIRED-RESISTANCE TO ANTHRACYCLINES AND VINCA ALKALOIDS INVIVO - A NEW TREATMENT PRINCIPLE
SKOVSGAARD, T
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV COPENHAGEN, INST PATHOL, TUMOR BIOL LAB, DK-1168 COPENHAGEN, DENMARK
SKOVSGAARD, T
DANO, K
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV COPENHAGEN, INST PATHOL, TUMOR BIOL LAB, DK-1168 COPENHAGEN, DENMARK
DANO, K
NISSEN, NI
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV COPENHAGEN, INST PATHOL, TUMOR BIOL LAB, DK-1168 COPENHAGEN, DENMARK
NISSEN, NI
[J].
CANCER TREATMENT REVIEWS,
1984,
11
: 63
-
72
←
1
2
→
共 17 条
[1]
BACHUR NR, 1970, CANCER CHEMOTH REP 1, V54, P89
[2]
DANO K, 1972, CANCER RES, V32, P1307
[3]
DANO K, 1971, CANCER CHEMOTH REP 1, V55, P133
[4]
DANO K, 1983, 13TH P INT CANC C C, V2, P231
[5]
TUMOR-CELL RESISTANCE TO ANTHRACYCLINES - A REVIEW
KAYE, S
论文数:
0
引用数:
0
h-index:
0
KAYE, S
MERRY, S
论文数:
0
引用数:
0
h-index:
0
MERRY, S
[J].
CANCER CHEMOTHERAPY AND PHARMACOLOGY,
1985,
14
(02)
: 96
-
103
[6]
INTERACTIONS BETWEEN CALCIUM-ANTAGONISTS, CALCIUM FLUXES AND ANTHRACYCLINE TRANSPORT
KESSEL, D
论文数:
0
引用数:
0
h-index:
0
机构:
WAYNE STATE UNIV,SCH MED,DEPT PHARMACOL,DETROIT,MI 48201
KESSEL, D
WILBERDING, C
论文数:
0
引用数:
0
h-index:
0
机构:
WAYNE STATE UNIV,SCH MED,DEPT PHARMACOL,DETROIT,MI 48201
WILBERDING, C
[J].
CANCER LETTERS,
1984,
25
(01)
: 97
-
101
[7]
KESSEL D, 1985, CANCER RES, V45, P1687
[8]
CALCIUM MODIFIES THE ACCUMULATION AND RETENTION OF DAUNORUBICIN BY EHRLICH ASCITES-CARCINOMA
MURRAY, SL
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CALIF IRVINE,COLL MED,DEPT MED,IRVINE,CA 92717
UNIV CALIF IRVINE,COLL MED,DEPT MED,IRVINE,CA 92717
MURRAY, SL
DUVALL, EM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CALIF IRVINE,COLL MED,DEPT MED,IRVINE,CA 92717
UNIV CALIF IRVINE,COLL MED,DEPT MED,IRVINE,CA 92717
DUVALL, EM
SLATER, LM
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV CALIF IRVINE,COLL MED,DEPT MED,IRVINE,CA 92717
UNIV CALIF IRVINE,COLL MED,DEPT MED,IRVINE,CA 92717
SLATER, LM
[J].
CANCER CHEMOTHERAPY AND PHARMACOLOGY,
1984,
13
(01)
: 69
-
70
[9]
REVERSAL OF ADRIAMYCIN RESISTANCE BY VERAPAMIL IN HUMAN OVARIAN-CANCER
ROGAN, AM
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,MED BRANCH,BLDG 10,ROOM 12N226,BETHESDA,MD 20205
ROGAN, AM
HAMILTON, TC
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,MED BRANCH,BLDG 10,ROOM 12N226,BETHESDA,MD 20205
HAMILTON, TC
YOUNG, RC
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,MED BRANCH,BLDG 10,ROOM 12N226,BETHESDA,MD 20205
YOUNG, RC
KLECKER, RW
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,MED BRANCH,BLDG 10,ROOM 12N226,BETHESDA,MD 20205
KLECKER, RW
OZOLS, RF
论文数:
0
引用数:
0
h-index:
0
机构:
NCI,DIV CANC TREATMENT,MED BRANCH,BLDG 10,ROOM 12N226,BETHESDA,MD 20205
OZOLS, RF
[J].
SCIENCE,
1984,
224
(4652)
: 994
-
996
[10]
CHEMOSENSITIZERS COUNTERACTING ACQUIRED-RESISTANCE TO ANTHRACYCLINES AND VINCA ALKALOIDS INVIVO - A NEW TREATMENT PRINCIPLE
SKOVSGAARD, T
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV COPENHAGEN, INST PATHOL, TUMOR BIOL LAB, DK-1168 COPENHAGEN, DENMARK
SKOVSGAARD, T
DANO, K
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV COPENHAGEN, INST PATHOL, TUMOR BIOL LAB, DK-1168 COPENHAGEN, DENMARK
DANO, K
NISSEN, NI
论文数:
0
引用数:
0
h-index:
0
机构:
UNIV COPENHAGEN, INST PATHOL, TUMOR BIOL LAB, DK-1168 COPENHAGEN, DENMARK
NISSEN, NI
[J].
CANCER TREATMENT REVIEWS,
1984,
11
: 63
-
72
←
1
2
→